Skip to Content

L409 (Darifenacin Hydrobromide Extended-Release 15 mg)

Pill with imprint L409 is Peach, Round and has been identified as Darifenacin Hydrobromide Extended-Release 15 mg. It is supplied by Alembic Pharmaceuticals Inc..

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L409

Darifenacin Hydrobromide Extended-Release

Imprint
L409
Strength
15 mg
Color
Peach
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
Manufacturer
Alembic Pharmaceutical Limited
National Drug Code (NDC)
62332-0224
Inactive Ingredients
hypromelloses, povidone k30, calcium phosphate dibasic anhydrous, magnesium stearate, titanium dioxide, polyethylene glycol 1500, magnesium silicate, ferric oxide yellow, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "L409"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.